ViVeTech Nyrt.

ViVeTech Nyrt.

BBUD:VVT
302.00
HUF
-2.00
(-0.66%)
3.68BMarket Cap
ViVeTech Nyrt.
BUD:VVT
(Budapest Stock Exchange)

Recent

price

302.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
HUF
21.42
71.12
73.68
77.44
93.29
115.23
188.21
- -
Revenue per Share
0.56
11.3
9.04
-5.77
5.46
10.62
15.68
- -
Basic EPS, GAAP
- -
13.8
-13.17
-40.8
-1.16
4.88
-8.08
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
21.55
22.97
32.01
37.87
43.33
53.53
71.2
71.2
Book Value per Share
10.56
13.02
23.04
3.75
14.45
26.95
47.76
47.76
Tangible Book Value per Share
12
12
12
12
12
12
12
12
Basic Weighted Avg Shares
260
863
894
939
1,131
1,397
2,325
- -
Sales/Revenue/Turnover
11.55
22.39
10.3
-5.56
13.27
15.8
23.7
- -
Operating Margin (%)
100
13
25
59
70
52
64
- -
Depreciation Expense
7
137
110
-70
66
129
194
- -
Net Income, GAAP
48.02
3.28
2.29
- -
2.73
- -
6.78
- -
Effective Tax Rate (%)
2.64
15.89
12.27
-7.45
5.85
9.22
8.33
- -
Profit Margin (%)
-90
-46
-162
-281
-101
55
453
453
Working Capital
- -
- -
- -
176
292
210
115
115
LT Debt
261
279
388
459
526
649
880
880
Total Equity
- -
51.66
25.51
- -
9.97
- -
43.13
- -
Return on Invested Capital (%)
- -
50.9
25.25
- -
10.57
- -
20.36
- -
Return on Capital (%)
- -
50.76
32.9
-16.5
13.44
21.92
25.35
- -
Return on Common Equity (%)

Capital Structure

HUF

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
174
173
86
LT Borrowings
210
210
115
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
12
12
12
Market Capitalization
3,032
3,590
3,682

Working Capital

HUF

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
436
577
918
Cash, Cash Equivalents & STI
27
91
170
Accounts Receivable, Net
267
241
610
Inventories
- -
- -
- -
Total Current Liabilities
381
466
464
Payables & Accruals
- -
- -
- -
ST Debt
174
173
86
Deferred Revenue
- -
- -
- -

Growth Rates

HUF

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
26.22%
35.49%
Free Cash Flow
- -
-174.43%
-268.77%
Net Income, GAAP
- -
-46.68%
50.47%
Sales/Revenue/Turnover
- -
23.82%
66.42%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HUF

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
1,131
2024
- -
- -
1,397
2025
- -
- -
2,325

Semi-annual Earnings Per Share

HUF

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
5.46
2024
- -
- -
10.62
2025
- -
- -
15.68

Semi-annual Dividends Per Share

HUF

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Business
ViVeTech Nyrt. provides specialized cybersecurity solutions, digital healthcare information systems, regulatory compliance software, and enterprise IT consulting services. Founded in 2011 and headquartered in Budapest, Hungary, the company operates primarily across Hungary and Central and Eastern Europe, catering to healthcare organizations, financial institutions, critical infrastructure operators, public administration bodies, and corporate enterprises. ViVeTech Nyrt. develops proprietary software platforms and delivers comprehensive professional services organized into core offerings: regulatory compliance and risk management software, including automated governance, risk, and compliance tools tailored for the European Union's NIS 2 directive, ISO/IEC 27001, and GDPR frameworks; cybersecurity services, comprising vulnerability assessments, penetration testing, ethical hacking, security architecture design, threat intelligence, and incident response management; digital health solutions, consisting of custom medical workflow management platforms, healthcare information system integrations, telemedicine applications, and medical data security infrastructure; and enterprise IT consulting, which includes bespoke software engineering, cloud migration, systems architecture optimization, and IT operational support. In recent developments, ViVeTech Nyrt. has expanded its software portfolio with automated audit and compliance modules designed to address European NIS 2 cybersecurity mandates; established strategic technology and distribution partnerships with regional systems integrators; broadened its healthcare IT engineering capacity to service expanding cross-border European market demand; and strengthened its capital market presence on the Budapest Stock Exchange (BÉT Xtend) to support proprietary product commercialization and regional operational growth.